Skip to content
Business

Gruppo San Donato Appoints Marco Rotelli as New President

The major Italian private healthcare network has renewed its board of directors, shifting its focus back to domestic operations and care excellence.

By 3 min read

The Gruppo San Donato, the leading private healthcare provider in Italy, announced a major leadership reshuffle on November 12, 2026, appointing Marco Rotelli as its new president. The restructuring marks a significant shift in governance as the organization prepares to approach its seventieth anniversary since its founding in 1957. The new board structure emphasizes family leadership combined with independent expertise to guide the company through its next strategic phase.

Marco Rotelli, a thirty-three-year-old representative of the third generation of the Rotelli family, stated that the new governance structure is designed to adapt the group's needs to the international geopolitical and macroeconomic environment. He succeeds former government minister Angelino Alfano, who had served as chairman since 2019. In addition to the leadership change, Gilda Gastaldi Rotelli was named honorary chair, while Marco Centenari was confirmed as chief executive officer, and Nicola Grigoletto assumed the role of vice president.

The newly reformed six-member board also welcomes three independent members: Stefano Firpo, general manager of Assonime; Marcella Panucci, an advisor to the Minister of University and Research and former general manager of Confindustria; and Giuseppe Tinelli, an attorney and professor. According to the company, these additions bring valuable institutional, economic, industrial, legal, and governance competencies to the leadership team.

Alongside Angelino Alfano, vice president Kamel Ghribi has departed from the board. Ghribi had previously led the group's international development initiatives, expanding its presence into markets such as Poland, the Middle East, and Africa. The transition coincides with a strategic pivot back toward domestic priorities.

Marco Rotelli emphasized that the organization's primary objective is to enhance its national healthcare assets and strengthen its commitment to the Italian National Health Service. "Our goal is to make national excellences grow so they become international benchmarks in treatment, research, and education," he said, noting the importance of facilities such as the San Raffaele, the Galeazzi, and the Policlinico San Donato. The group currently operates sixty-one medical centers, including eighteen hospitals, employs over nineteen thousand people, and serves more than five million patients annually.

The renewed focus on domestic healthcare follows a period of heavy investment totaling around two billion euros over the past thirteen years, aimed at upgrading infrastructure, expanding technology, and increasing staffing. The company currently ranks as the second-largest research player in Italy behind the National Research Council and intends to continue generating qualified employment while reinforcing its dedication to patient care, education, and scientific research.

Sources

Related stories